Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Pick Your Number one breakfast food - 2VPN Administrations for Online Protection
- 3Gaza amputees struggle to rebuild lives as the enclave faces shortages of prosthetic limbs
- 4Key Business Regulations to Consider While Arranging Your Independent venture
- 57 Fun Plans to Make Film Evenings Seriously Invigorating (You'll Cherish #5!)
- One third of Spanish pork export certificates blocked since swine fever outbreak, minister says
- The Solution to Defeating Tarrying: Systems for Expanded Efficiency
- Emotional wellness Matters: My Fight with Tension
- Emergency services search for five people last seen in missing Jeep
- The Best Internet Mastering Stages for Expertise Improvement
- Figure out What Shift Differentials Mean for Your General Attendant Compensation
- A Manual for Extravagant Vehicles Available in 2024
- AstraZeneca to invest $2 billion as part of US manufacturing push
- The Universe of Impeccable Pearls: A Manual for Valuable Gems
